NO951126L - Transdermalt matrikssystem basert på en styren-isopren-styren-kopolymer for administrasjon av et östrogen og/eller et progestogen - Google Patents

Transdermalt matrikssystem basert på en styren-isopren-styren-kopolymer for administrasjon av et östrogen og/eller et progestogen

Info

Publication number
NO951126L
NO951126L NO951126A NO951126A NO951126L NO 951126 L NO951126 L NO 951126L NO 951126 A NO951126 A NO 951126A NO 951126 A NO951126 A NO 951126A NO 951126 L NO951126 L NO 951126L
Authority
NO
Norway
Prior art keywords
styrene
pts
isoprene
progestogen
estrogen
Prior art date
Application number
NO951126A
Other languages
English (en)
Norwegian (no)
Other versions
NO951126D0 (no
Inventor
Claude Mikler
Laurent Liorzou
Daniel Dhuique-Mayer
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of NO951126D0 publication Critical patent/NO951126D0/no
Publication of NO951126L publication Critical patent/NO951126L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
NO951126A 1994-03-28 1995-03-24 Transdermalt matrikssystem basert på en styren-isopren-styren-kopolymer for administrasjon av et östrogen og/eller et progestogen NO951126L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403599A FR2717689B1 (fr) 1994-03-28 1994-03-28 Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.

Publications (2)

Publication Number Publication Date
NO951126D0 NO951126D0 (no) 1995-03-24
NO951126L true NO951126L (no) 1995-09-29

Family

ID=9461479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951126A NO951126L (no) 1994-03-28 1995-03-24 Transdermalt matrikssystem basert på en styren-isopren-styren-kopolymer for administrasjon av et östrogen og/eller et progestogen

Country Status (23)

Country Link
US (1) US5580572A (hu)
EP (1) EP0674901B1 (hu)
JP (1) JPH07330609A (hu)
KR (1) KR950031057A (hu)
CN (1) CN1114903A (hu)
AT (1) ATE173618T1 (hu)
AU (1) AU691558B2 (hu)
CA (1) CA2145584A1 (hu)
CZ (1) CZ76795A3 (hu)
DE (1) DE69506157T2 (hu)
DK (1) DK0674901T3 (hu)
ES (1) ES2128673T3 (hu)
FI (1) FI951424A (hu)
FR (1) FR2717689B1 (hu)
GR (1) GR3029401T3 (hu)
HU (1) HU219465B (hu)
LV (1) LV10929B (hu)
NO (1) NO951126L (hu)
NZ (1) NZ270811A (hu)
PL (1) PL178896B1 (hu)
RU (1) RU2110282C1 (hu)
SK (1) SK39095A3 (hu)
ZA (1) ZA952469B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58909570D1 (de) * 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
US6148830A (en) 1994-04-19 2000-11-21 Applied Elastomerics, Inc. Tear resistant, multiblock copolymer gels and articles
US7134236B2 (en) * 1994-04-19 2006-11-14 Applied Elastomerics, Inc. Gelatinous elastomer compositions and articles for use as fishing bait
US7234560B2 (en) * 1994-04-19 2007-06-26 Applied Elastomerics, Inc. Inflatable restraint cushions and other uses
WO1996015776A1 (fr) * 1994-11-18 1996-05-30 Hisamitsu Pharmaceutical Co., Inc. Timbre absorbable par voie percutanee
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
JP3857348B2 (ja) * 1996-02-20 2006-12-13 ソニー株式会社 テープカートリッジ
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
WO2001001990A1 (fr) * 1999-07-01 2001-01-11 Hisamitsu Pharmaceutical Co., Inc. Preparation adhesive pour absorption percutanee
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
US20050191339A1 (en) * 2002-08-08 2005-09-01 Beiersdorf Ag Skin friendly active ingredient plaster based on SBC, containing at least 34 WT.% of a pharmaceutical active ingredient and production thereof
DE10236319A1 (de) * 2002-08-08 2004-02-19 Beiersdorf Ag Hautfreundliche Wirkstoffpflaster auf der Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff mit einem Gehalt von mindestens 34 Gew.-% und dessen Herstellung
JP2004224741A (ja) * 2003-01-23 2004-08-12 Hisamitsu Pharmaceut Co Inc ツロブテロール経皮吸収型製剤
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
JP4311728B2 (ja) * 2003-12-10 2009-08-12 ニチバン株式会社 経皮吸収型貼付剤
DE102004028284A1 (de) * 2004-06-11 2006-01-05 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin
US20070062884A1 (en) 2005-08-11 2007-03-22 Board Of Regents, The University Of Texas System N-halamines compounds as multifunctional additives
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299501A (en) * 1979-08-10 1981-11-10 Ortho Pharmaceutical Corporation Continuous process for the preparation of semisolid dispersions
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5032402A (en) * 1988-10-27 1991-07-16 The University Of Kentucky Research Foundation 3-hydroxy-N-methylpyrrolidone and use as transdermal enhancer
ATE120368T1 (de) * 1990-05-17 1995-04-15 Hisamitsu Pharmaceutical Co Estradiol enthaltende transdermale zubereitung.
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
JPH05331064A (ja) * 1992-05-26 1993-12-14 Sekisui Chem Co Ltd 消炎鎮痛貼付剤

Also Published As

Publication number Publication date
PL307891A1 (en) 1995-10-02
EP0674901B1 (fr) 1998-11-25
HU9500880D0 (en) 1995-05-29
DK0674901T3 (da) 1999-08-09
EP0674901A1 (fr) 1995-10-04
HUT75238A (en) 1997-05-28
SK39095A3 (en) 1995-10-11
DE69506157D1 (de) 1999-01-07
CN1114903A (zh) 1996-01-17
DE69506157T2 (de) 1999-07-01
AU691558B2 (en) 1998-05-21
CZ76795A3 (en) 1995-10-18
ES2128673T3 (es) 1999-05-16
AU1497895A (en) 1995-10-05
ATE173618T1 (de) 1998-12-15
RU2110282C1 (ru) 1998-05-10
ZA952469B (en) 1995-12-19
LV10929B (en) 1996-08-20
FR2717689B1 (fr) 1996-07-05
KR950031057A (ko) 1995-12-18
NO951126D0 (no) 1995-03-24
NZ270811A (en) 1995-12-21
PL178896B1 (pl) 2000-06-30
FI951424A0 (fi) 1995-03-24
HU219465B (hu) 2001-04-28
LV10929A (lv) 1995-12-20
JPH07330609A (ja) 1995-12-19
US5580572A (en) 1996-12-03
GR3029401T3 (en) 1999-05-28
FI951424A (fi) 1995-09-29
CA2145584A1 (en) 1995-09-29
FR2717689A1 (fr) 1995-09-29

Similar Documents

Publication Publication Date Title
NO951126D0 (no) Transdermalt matriks-system basert på en styren-isopren-styren-kopolymer for administrasjon av et östrogen og/eller et progestogen
NO951125D0 (no) Transdermalt matriks-system basert på EVA for administrasjon av et östrogen og/eller et progestogen
CN100536835C (zh) 用于雌二醇与另一种类固醇物质共同给药的透皮释药基质
NO981315L (no) Transdermalt matrikssystem
KR920700601A (ko) 피부투과 증진제 조성물
DE69714327D1 (de) Sternförmiges Styrol-Isopren-Styrol enthaltender druckempfindlicher Klebstoff für Etiketten
ES2071683T3 (es) Sistema de suministro de un farmaco transdermico a base de multipolimero acrilico.
AU635021B2 (en) Extended release pharmaceutical formulations
AU2402692A (en) Anti-inflammatory analgesic plaster
CA2277970A1 (en) Composition for the transdermal administration of steroid drugs
ES8403323A1 (es) Instrumento canular para fluidos parenterales.
ES2004286A6 (es) Disolvente para material cromogenico precursor de tintes, para hojas de papel de inscripcion sensible a la presion y hoja de papel sensible a la presion preparada mediante el disolvente
KR920002137A (ko) 경피흡수용 스테로이드 호르몬 제제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application